FOR LIVE SUPPORT, CALL 1-877-744-5675
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of your body.
Your healthcare provider will perform a test to make sure that LORBRENA is right for you.
It is not known if LORBRENA is safe and effective in children.
LORBRENA ® (lorlatinib) is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene and that has spread to other parts of your body.
Your healthcare provider will perform a test to make sure that LORBRENA is right for you.
It is not known if LORBRENA is safe and effective in children.


About ALK+ mNSCLC
Non–small cell lung cancer (NSCLC) is the most common type of lung cancer. When NSCLC spreads to other parts of the body, it is described as metastatic, or mNSCLC.
NSCLC can also be further described based on genetic changes found in cancer cells. One of these changes involves a gene called ALK. A mutation in this ALK gene causes the cells to multiply out of control, resulting in cancer growth. When an NSCLC tumor has an ALK gene mutation, it is called ALK‑positive (ALK+) NSCLC.
Put together, ALK+ mNSCLC is a type of lung cancer with changes in the ALK gene that has spread to other parts of the body. It can affect anyone, no matter their age, race, or background—even people who have never smoked.
Today, targeted therapy—a precise type of cancer treatment that identifies and attacks specific parts of cancer cells—is an option for people whose cancer has a change in the ALK gene. Medicines that target a change in the ALK gene are called ALK inhibitors, and they are a type of targeted therapy. ALK inhibitors are taken by mouth and are used to treat ALK+ mNSCLC. LORBRENA is one of the treatment options in this group.
It is important to know that targeted therapies may also affect healthy cells.
Use this guide to help you talk with your doctor about your diagnosis, potential treatment options, and resources available to you.
Download
Patient was compensated for her time.
–Grace, patient taking LORBRENA
Watch her storyTurn to Pfizer Oncology Together for financial assistance resources and personalized support.
Call
1-877-744-5675
(Monday–Friday 8
AM–8
PM ET)
If you get serious side effects during treatment, your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with LORBRENA.
Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. Taking LORBRENA with certain other medicines may increase your risk of side effects and may affect the way LORBRENA or the other medicines work.
Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
Do not take LORBRENA if you take certain other medicines called strong CYP3A inducers. Ask your healthcare provider for a list of these medicines if you are not sure.
LORBRENA may cause decreased fertility in males, which may affect your ability to have children. Talk to your healthcare provider if you have concerns about fertility.
These are not all of the possible side effects of LORBRENA.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
LORBRENA is a prescription medicine that is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by an abnormal anaplastic lymphoma kinase (ALK) gene, and that has spread to other parts of your body (metastatic).
Your healthcare provider will perform a test to make sure that LORBRENA is right for you.
It is not known if LORBRENA is safe and effective in children.
Please see Full Prescribing Information and Patient Information.